Prot# S320.2.011: A Double-Blind, Placebo-Controlled, Randomize, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized with Acute Decompensat

  • Courtney, D Mark (PD/PI)

Project: Research project

Project Details

Effective start/end date3/17/093/17/12


  • Quintiles, Inc. (S320.2.011 // S320.2.011)
  • Solvay Pharmaceuticals, Inc. (S320.2.011 // S320.2.011)